BioLineRX Ltd.

04/17/2024 | Press release | Distributed by Public on 04/17/2024 05:44

BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA[...]